drugset / Trial / NCT04524169

Immunotherapy for Elderly Patients With Chronic Osteoporotic Pain

NCT04524169

Phase 4 Unknown 100 enrolled RenJi Hospital
RandomizedParallel-groupDouble-blindTreatment

Summary

Osteoporotic pain is the most common clinical symptom in elderly patients. The course of pain is prolonged and the effect of clinical treatment is limited. This study will observe the therapeutic effect of thymosin alpha 1 on elderly patient with osteoporotic pain and explore its immunotherapy mechanism.

Timeline

Start
2020-11-01
Primary completion
2021-12-31
Completion
2021-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Thymalfasin Peptide Subcutaneous

Indications